https://thepharmadata.com/me-therapeutics-licenses-cd22-to-therapy-advance/ 2025-10-17T17:31:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Cabinet__FitMaxWzgwMCw4MDBd_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/10/shutterstock_497282461-1_11zon-1024x768.webp https://thepharmadata.com/emd-serono-landmark-deal-with-therapy-access/ 2025-10-17T17:00:23+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/1700656695711_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/10/Cabinet__FitMaxWzgwMCw4MDBd_11zon-1.webp https://thepharmadata.com/roquette-launches-in-latin-america/ 2025-10-17T17:26:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/lab-3498584_1280_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/10/medications-1853400_1280_11zon-1024x682.webp https://thepharmadata.com/roche-reveals-2-phase-iii-trial-for-edema/ 2025-10-18T10:16:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/medical-equipment-4099431_1280.jpg https://thepharmadata.com/wp-content/uploads/2025/10/roche.jpg https://thepharmadata.com/agenus-shows-39-two-year-survival-with-bot-2025/ 2025-10-18T12:12:40+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Agenus_11zon-1.webp https://thepharmadata.com/tezspire-wins-u-s-approval-for-nasal-polyps/ 2025-10-18T12:21:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/signing-6598540_1280_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/10/cenetered-Biologics-for-ADs.png_11zon_11zon-1-1024x576.webp https://thepharmadata.com/catalym-shows-promising-phase-2-results-for/ 2025-10-18T12:25:24+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/CatalYm-Shows-Promising-Phase-2-Results-for-Visugromab-PD-1-Inhibitor-in-Neoadjuvant-Bladder-Cancer-at-ESMO_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/10/CatalYm-1024x1024.webp https://thepharmadata.com/chmp-recommends-saphnelo-use-for-lupus-in-eu/ 2025-10-18T12:37:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/cheques-2672195_1280_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/10/pharmacy-4496863_960_720_11zon.webp https://thepharmadata.com/chmp-gives-positive-opinion-newly-diagnosed-cml/ 2025-10-18T13:04:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/drugs-7055179_1280_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/10/novartis-logo-open-graph_11zon-1024x538.webp https://thepharmadata.com/novartis-kisqali-5-year-dataearly-breast-cancer/ 2025-10-20T11:20:11+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Novartis-Kisqali®-Shows-Sustained-Five-Year-Benefit-in-Broad-Early-Breast-Cancer-Population.jpg https://thepharmadata.com/wp-content/uploads/2025/10/doctor-563429_1280-1_11zon-1024x682.webp https://thepharmadata.com/fiji-achieves-milestone-as-the-26th-country-to-eliminate-trachoma-as-a-public-health-concern/ 2025-10-20T11:50:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Fiji-Achieves-Milestone-as-the-26th-Country-to-Eliminate-Trachoma-as-a-Public-Health-Concern.webp https://thepharmadata.com/hansoh-pharma-presents-phase-2-data-on-hs-20089-for-platinum-resistant-ovarian-cancer-at-esmo-2025/ 2025-10-20T12:14:44+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Hansoh-Pharma-Presents-Phase-2-Data-on-HS-20089-for-Platinum-Resistant-Ovarian-Cancer-at-ESMO-2025.webp https://www.hspharm.com/upload/images/2025/10/20/5f154ac668c24bbd8c74779e29eda42c.jpg https://thepharmadata.com/counteracting-complacency-in-multiple-myeloma-the-fight-is-far-from-over/ 2025-10-20T13:00:16+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/pexels-rdne-6129152.webp https://thepharmadata.com/roches-gazyva-secures-fda-approval-for-lupus-marking-expansion-beyond-cancer/ 2025-10-21T12:21:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/01/Incyte-and-Syndax-Announce-FDA-Approval-of-Niktimvou2122-Axatilimab-in-9-mg-and-22-mg-Vials_11zon.webp https://thepharmadata.com/replimune-shares-surge-after-fda-resubmission-for-advanced-melanoma-therapy/ 2025-10-21T13:00:26+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/pexels-shvetsa-4586728.webp https://thepharmadata.com/idweek-2025-shionogi-highlights-data-supporting-cefiderocols-srole-in-tough-to-treat-infections/ 2025-10-21T15:32:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Laboratory-setting.webp https://thepharmadata.com/wuxi-biologics-receives-2025/ 2025-10-21T16:04:57+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Leadership-Award.webp https://thepharmadata.com/wp-content/uploads/2025/10/WuXi-Biologics-1.webp https://thepharmadata.com/biopharma-early-signs-of-employee-turnover/ 2025-10-22T17:18:31+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/pexels-olia-danilevich-5313179.webp https://thepharmadata.com/wp-content/uploads/2025/10/Vividion-Publishes-Preclinical-Data-in-Science-on-Novel-RAS-PI3K-Inhibitors-Blocking-Tumor-Growth_11zon-1024x768.webp https://thepharmadata.com/biotech-markets-turn-positive/ 2025-10-22T17:51:38+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/pexels-yankrukov-7693745_1.webp https://thepharmadata.com/wp-content/uploads/2025/10/httpsthepharmadata.combuilt-biotechnologies-named-anchor-company-atdna-1024x678.webp https://thepharmadata.com/mers-cov-added-to-who-biohu-mers-cov-virus/ 2025-10-24T11:22:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/MERS-CoV-virus-isolate-added-to-the-WHO-BioHub-System_-enabling-further-research-and-pandemic-prepar-2.webp https://thepharmadata.com/wp-content/uploads/2025/10/MERS-CoV-virus-isolate-added-to-the-WHO-BioHub-System-enabling-further-research-and-pandemic-preparedness-2-1024x682.jpg https://thepharmadata.com/arcturus-plunges-mixed-cystic-inhaled-mrna-drug/ 2025-10-24T12:30:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/pexels-towfiqu-barbhuiya-3440682-8395815.webp https://thepharmadata.com/wp-content/uploads/2025/10/Arcturus-Plunges-on-‘Mixed-Cystic-Fibrosis-Data-for-Inhaled-mRNA-Drug-1024x682.webp https://thepharmadata.com/hs-10365-capsules-to-treat-ret-positive-nsclc/ 2025-10-24T12:57:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Chinas-NMPA-Accepts-New-Drug-Application-for-HS-10365-Capsules-to-Treat-RET-Fusion-Positive-NSCLC.webp https://thepharmadata.com/wp-content/uploads/2025/10/Chinas-NMPA-Accepts-New-Drug-Application-for-HS-10365-Capsules-to-Treat-RET-Fusion-Positive-NSCLC-2-1024x682.webp https://thepharmadata.com/biogen-expands-immunology-portfolio/ 2025-10-25T11:52:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/download.webp https://thepharmadata.com/wp-content/uploads/2024/10/LabGenomics-USA-Finalizes-Acquisition-of-IMD-CLIA-Labs_11zon.webp https://thepharmadata.com/lilly-dives-deeper-into-gene-therapy/ 2025-10-25T12:12:38+05:30 https://thepharmadata.com/wp-content/uploads/2024/12/LillyApplauds-ITC-Ruling-on-Counterfeit-Tirzepatide-Imports_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/01/Lilly-to-Acquire-Scorpion-Therapeutics-Precision-PI3Kα-Inhibitor-Program-2-1024x537.webp https://thepharmadata.com/regeneron-drops-2seventys-car-t-cell/ 2025-10-25T12:29:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/download-_1_.webp https://thepharmadata.com/uniqures-huntingtons-breakthrough/ 2025-10-27T15:56:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/UniQures-Huntingtons-Breakthrough-Brings-Hope-to-Patients-but-Experts-Urge-Cautio-_2_-3.webp https://thepharmadata.com/wp-content/uploads/2025/10/UniQures-Huntingtons-Breakthrough-Brings-Hope-to-Patients-but-Experts-Urge-Cautio-1-1024x682.webp https://thepharmadata.com/huntingtons-disease-therapies/ 2025-10-27T16:22:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Four-Huntingtons-Disease-Therapies-Racing-to-Catch-Up-with-UniQure-1.webp https://thepharmadata.com/wp-content/uploads/2025/10/Four-Huntingtons-Disease-Therapies-Racing-to-Catch-Up-with-UniQure-2-1-1024x682.webp https://thepharmadata.com/lecanemab-health-canada-approves-alzheimer/ 2025-10-27T16:52:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/pexels-cottonbro-5721384.webp https://thepharmadata.com/wp-content/uploads/2025/10/Health-Canada-Approves-LEQEMBI®-lecanemab-for-the-Treatment-of-Early-Stage-Alzheimers-Disease-1024x682.webp https://thepharmadata.com/gsk-and-empirico-sign-licensing-deal/ 2025-10-28T15:32:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/GSK-and-Empirico-enter-license-agreement-for-clinical-stage-first-in-class-oligonucleotide-candidate-to-treat-respiratory-diseases-2.webp https://thepharmadata.com/wp-content/uploads/2025/10/GSK-and-Empirico-enter-license-agreement-for-clinical-stage-first-in-class-oligonucleotide-candidate-to-treat-respiratory-diseases-1-1024x682.webp https://thepharmadata.com/roche-announces-positive-phase-gazyvaidiopathic/ 2025-10-28T16:12:17+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Positive-phase-III-results-for-Roches-GazyvaGazyvaro-in-children-and-young-adults-with-idiopathic-nephrotic-syndrome-2.webp https://thepharmadata.com/wp-content/uploads/2025/10/Positive-phase-III-results-for-Roches-GazyvaGazyvaro-in-children-and-young-adults-with-idiopathic-nephrotic-syndrome-1024x682.webp https://thepharmadata.com/pharma-companies-hope-fda-precheck/ 2025-10-28T16:38:52+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Pharmas-Hope-FDA-PreCheck-Can-Help-Avoid-Facility-Related-Drug-Rejections-2.webp https://thepharmadata.com/wp-content/uploads/2025/10/Pharmas-Hope-FDA-PreCheck-Can-Help-Avoid-Facility-Related-Drug-Rejections-1024x576.webp https://thepharmadata.com/biopharm-vaccine/ 2025-10-28T17:06:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/pexels-tara-winstead-7723205.webp https://thepharmadata.com/wp-content/uploads/2025/10/Opinion-A-Flu-Season-in-Flux-Presents-Risks_-Opportunities-for-Biopharma-1024x683.webp https://thepharmadata.com/5-small-mid-cap-pharma-companies-ripe-ma/ 2025-10-29T17:20:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/5-Small-and-Mid-Cap-Pharma-Companies-Ripe-for-MA-Deals.webp https://thepharmadata.com/wp-content/uploads/2025/10/pexels-castorlystock-4058296-1024x682.webp https://thepharmadata.com/fda-faces-operational-strain-amid-government/ 2025-10-29T18:18:02+05:30 https://thepharmadata.com/wp-content/uploads/2025/09/FDA-Expands-Approval-of-VONVENDI-for-Von-Willebrand-Disease-in-Adults-and-Children.webp https://thepharmadata.com/wp-content/uploads/2025/07/FDA-Rejections-Explained-We-Analyzed-200-CRLs-for-You_11zon.webp https://thepharmadata.com/fda-rejects-regenerons-eylea-hd-citing/ 2025-10-29T18:36:56+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/FDA-Formally-Rejects-Regenerons-Eylea-HD-Over-Manufacturing-Issues.webp https://thepharmadata.com/wp-content/uploads/2025/05/Regeneron-Wins-Antitrust-Suit-Against-Amgen-Over-PCSK9-Drug-Access_11zon.webp https://thepharmadata.com/biospace-nearly-one-third-of-life-sciences/ 2025-11-01T09:43:27+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Almost-13-Eyeing-Job-Options-Outside-US_-BioSpace-Finds-_2_.webp https://thepharmadata.com/wp-content/uploads/2025/10/Almost-13-Eyeing-Job-Options-Outside-US_-BioSpace-Finds-1024x664.webp https://thepharmadata.com/lupin-digital-health-unveils-vitalyfe/ 2025-10-30T17:34:39+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Lupin-Unveils-New-Consumer-Healthcare-Arm-LupinLife.webp https://thepharmadata.com/wp-content/uploads/2025/05/Lupin-Secures-FDA-Nod-for-600-mg-Raltegravir-Tablets-USP-1024x682.webp https://thepharmadata.com/kyowa-kirin-international-names-julie/ 2025-11-04T10:00:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Kyowa-Kirin-International-Names-Julie-Dehaene-Puype-as-New-Regional-President_11zon.webp https://thepharmadata.com/anxiety-disorder-completes-phase-3-palisade-3/ 2025-11-04T10:17:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Vistagen-Completes-Phase-3-PALISADE-3-Trial-for-Social-Anxiety-Disorder_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Anxiety_11zon-1024x615.webp https://thepharmadata.com/auna-s-a-reports-early-results-cash-tender-2029/ 2025-11-04T10:39:33+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Auna-S.A.-Reports-Early-Results-of-Cash-Tender-Offer-and-Consent-Solicitation-for-2029-Notes_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Auna_11zon.webp https://thepharmadata.com/doseme-acquires-firstline-to-advance-global/ 2025-11-04T10:48:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/DoseMe-Acquires-Firstline-to-Advance-Global-Infectious-Disease-Decision-Support_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Dose_11zon-1024x768.webp https://thepharmadata.com/puretechs-gallop-oncology-to-present1b-lyt-200/ 2025-11-04T10:56:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/PureTechs-Gallop-Oncology-to-Present-Phase-1b-LYT-200-AML-Data-at-ASH-Meeting.webp https://thepharmadata.com/wp-content/uploads/2025/08/oncology-research_11zon-1024x538.webp https://thepharmadata.com/genetix-biotherapeutics-to-share-u-s-gene-2025/ 2025-11-04T11:12:11+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Genetix-Biotherapeutics-to-Share-U.S.-Gene-Therapy-Patient-Experience-Data-at-ASH-2025_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/pexels-googledeepmind-18069422_11zon-1024x768.webp https://thepharmadata.com/vertex-announces-third-quarter-2025-financial/ 2025-11-04T11:21:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Vertex-Announces-Third-Quarter-2025-Financial-Results_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Vertex-Announces-Third-Quarter-2025-Financial-Results_11zon-1.webp https://thepharmadata.com/zoetis-names-kevin-esch-rd-president-2026/ 2025-11-04T11:29:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Zoetis-Names-Kevin-Esch-as-New-RD-President-Succeeding-Rob-Polzer-in-2026_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/05/Dr.-Mark-Stetter-Joins-Zoetis-Board-of-Directors-Following-Election_11zon.webp https://thepharmadata.com/serenity-mental-health-launches-ketamine/ 2025-11-05T09:44:57+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Serenity-Mental-Health-Launches-Ketamine-Treatment-in-Colorado-Springs_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Serenity-Mental_11zon-1024x681.webp https://thepharmadata.com/zetagen-to-share-phase-2-bone-metastatic2025/ 2025-11-05T09:57:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Zetagen-to-Share-Phase-2-Data-on-Bone-Metastatic-Breast-Cancer-at-SABCS-2025_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Zetagen_11zon-1024x681.webp https://thepharmadata.com/pharmajet-to-present-intradermal-program-results/ 2025-11-05T10:15:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/PharmaJet-to-Present-Intradermal-Program-Results-at-ASTMH-Meeting_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/PharmaJet_11zon-1024x681.webp https://thepharmadata.com/transplant-nmdp-to-showcase-new-research-2025/ 2025-11-05T10:29:05+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/NMDP-to-Showcase-New-Research-Driving-Improved-Transplant-Access-and-Cell-Therapy-Innovation-at-ASH-2025_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Transplant_11zon-1024x681.webp https://thepharmadata.com/qiagen-buys-parse-biosciences-to-expand-single/ 2025-11-05T10:36:25+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/QIAGEN-Buys-Parse-Biosciences-to-Expand-Single-Cell-Tools_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Biosciences_11zon-1024x681.webp https://thepharmadata.com/biospace-honors-engene-as-a-2026-best-place-to/ 2025-11-05T10:45:25+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/BioSpace-Honors-enGene-as-a-2026-Best-Place-to-Work_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/enGene_11zon-1024x576.webp https://thepharmadata.com/catalent-showcases-smartag-adc-pipeline/ 2025-11-05T10:53:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Catalent-Showcases-SMARTag®-ADC-Pipeline-at-World-ADC-San-Diego.webp https://thepharmadata.com/wp-content/uploads/2025/11/Catalent.webp https://thepharmadata.com/stoke-therapeutics-announces-q3-2025-results/ 2025-11-05T11:01:20+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Stoke-Therapeutics-Announces-Q3-2025-Results-Business-Update_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Stoke-Therapeutics_11zon-1024x678.webp https://thepharmadata.com/mirum-pharmaceuticals-announces-q3-2025/ 2025-11-05T11:08:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Mirum-Pharmaceuticals-Announces-Q3-2025-Financial-Results-and-Business-Highlights_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Mirum-Pharmaceuticals_11zon-1024x681.webp https://thepharmadata.com/ondex-automation-buys-plantops-to-boost-life/ 2025-11-06T10:13:10+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Ondex-Automation-Buys-PlantOPS-Consulting-to-Boost-Life-Sciences_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/PlantOPS-2_11zon-1024x681.webp https://thepharmadata.com/northwell-study-promising-chronic-epilepsy/ 2025-11-06T10:27:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Northwell-Study-Shows-Promising-Seizure-Reduction-for-Chronic-Epilepsy-Patients_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Epilepsy_11zon-1024x682.webp https://thepharmadata.com/biomunex-showcases-mait-engager-preclinical-2025/ 2025-11-08T10:14:14+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Biomunex-Showcases-MAIT-Engager-Preclinical-Data-at-2025-SITC_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Biomunex_11zon.webp https://thepharmadata.com/liver-meeting-mirum-highlights-livmarli/ 2025-11-08T10:24:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Mirum-Highlights-LIVMARLI®-and-Volixibat-Data-at-AASLD-Liver-Meeting®.webp https://thepharmadata.com/wp-content/uploads/2025/11/Liver-1024x733.png https://thepharmadata.com/gilead-shares-new-findings-phase-3-ascent-07/ 2025-11-08T10:34:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Gilead-Shares-New-Findings-from-Phase-3-ASCENT-07-Trial_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Gilead_11zon-1024x681.webp https://thepharmadata.com/synthekine-reports-positive-phase-1-results-012/ 2025-11-08T10:44:44+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Synthekine-Reports-Positive-Early-Phase-1-Results-for-STK-012-Combo-in-First-Line-PD-L1-Negative-NSCLC_11zon.webp https://thepharmadata.com/allogeneic-indapta-highlights-clinical-activity/ 2025-11-08T11:15:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Indapta-Highlights-Clinical-Activity-of-Allogeneic-NK-Therapy-in-RR-Multiple-Myeloma_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Allogeneic_11zon-1024x615.webp https://thepharmadata.com/fasenra-delays-disease-flares-in-phase-iii-hes/ 2025-11-08T11:24:53+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/FASENRA-Delays-Disease-Flares-in-Phase-III-HES-Trial_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Disease_11zon-1024x681.webp https://thepharmadata.com/aulos-bioscience-phase-2-results-imneskibart/ 2025-11-08T11:34:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Aulos-Bioscience-Phase-2-Results-Show-Imneskibart-Activity-in-Melanoma-and-NSCLC_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Bioscience_11zon-1024x681.webp https://thepharmadata.com/crossbridge-bio-named-best-drug-developer2025/ 2025-11-08T11:41:01+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/CrossBridge-Bio-Named-Best-Drug-Developer-at-2025-World-ADC-Awards.webp https://thepharmadata.com/wp-content/uploads/2025/11/Drug-1024x682.jpg https://thepharmadata.com/onchilles-pharma-publishes-pathway-n17350/ 2025-11-08T11:49:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Onchilles-Pharma-Publishes-ELANE-Pathway-Study-Advances-N17350-With-New-Funding_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Onchilles-Pharma-1024x681.webp https://thepharmadata.com/aortic-kardigan-reports-positive-phase-2-results/ 2025-11-08T12:08:06+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Kardigan-Reports-Positive_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Aortic-Stenosis_11zon-1024x681.webp https://thepharmadata.com/city-therapeutics-submits-clinical-trial/ 2025-11-11T09:56:09+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/City-Therapeutics-Submits-Clinical-Trial-Application-for-CITY-FXI_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Therapeutics_11zon-1024x681.webp https://thepharmadata.com/cancer-revvity-mdic-and-nist-launch-somatic/ 2025-11-11T10:16:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Revvity-MDIC-and-NIST-Launch-Somatic-Cancer-Reference-Standards-to-Ensure-Diagnostic-Accuracy_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Cancer_11zon-1024x681.webp https://thepharmadata.com/curasen-reports-positive-phase-1-data-at-2025/ 2025-11-11T10:29:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/CuraSen-Reports-Positive-Phase-1-Data-for-CuraAX-CST-3056-at-2025-AAS-Symposium_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/CuraSen_11zon-1024x516.webp https://thepharmadata.com/tfda-approves-orphan-drug-designation/ 2025-11-11T10:41:28+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/TFDA-Approves-Orphan-Drug-Designation-for-Tinostamustine-in-Malignant-Glioma_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Orphan-Drug_11zon-1024x681.webp https://thepharmadata.com/pharmaessentia-usa-appoints-dr-barry-flannelly/ 2025-11-11T10:50:43+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/PharmaEssentia-USA-Appoints-Dr.-Barry-Flannelly-as-Independent-Director_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/PharmaEssentia_11zon-1024x681.webp https://thepharmadata.com/arcturus-therapeutics-reports-third-quarter-2025/ 2025-11-11T11:15:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Arcturus-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Pipeline-Updates_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Therapeutics-2_11zon-1024x724.webp https://thepharmadata.com/samsung-epis-holdings-launches-epis-nexlab/ 2025-11-12T16:31:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Samsung-Epis-Holdings-Launches-Epis-NexLab-to-Drive-Next-Gen-Biotech-Innovation_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Epis-NexLab_11zon-1024x681.webp https://thepharmadata.com/fda-approves-promega-oncomate-msi-dx-as/ 2025-11-12T16:38:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/FDA-Approves-Promega-OncoMate-MSI-Dx-as-Companion-Test-for-KEYTRUDA-LENVIMA-in-Endometrial-Cancer_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/OncoMate.webp https://thepharmadata.com/engenes-detalimogene-shows-improved-six-62/ 2025-11-12T17:20:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/enGene-Holdings-Inc._11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/enGene-Holdings-Inc._11zon-1024x576.webp https://thepharmadata.com/ionis-pharmaceuticals-announces-new-2026/ 2025-11-12T17:19:31+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Ionis-Pharmaceuticals-Announces-New-Convertible-Offering-for-2026-Note-Refinancing_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Pharmaceuticals_11zon-1024x681.webp https://thepharmadata.com/dyno-therapeutics-trisk-bio-form-strategic/ 2025-11-13T09:37:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Dyno-Therapeutics-Trisk-Bio-Form-Strategic-Manufacturing-Partnership_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Therapeutics-3_11zon-1024x682.webp https://thepharmadata.com/deciphera-to-showcase-new-clinical-data-the-2025/ 2025-11-13T09:49:02+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Deciphera-to-Showcase-New-Clinical-Data-at-the-2025-CTOS-Annual-Meeting_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Deciphera_11zon.webp https://thepharmadata.com/kezar-life-sciences-announces-q3-2025-financial/ 2025-11-13T09:59:20+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Kezar-Life-Sciences-Announces-Q3-2025-Financial-Results_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Life-Sciences_11zon-1024x681.webp https://thepharmadata.com/an2-therapeutics-announces-q3-2025-financial/ 2025-11-13T10:10:49+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/AN2-Therapeutics-Announces-Q3-2025-Financial-Results-and-Key-Corporate-Scientific-Updates_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/AN2-Therapeutics_11zon-1024x682.webp https://thepharmadata.com/koru-medical-systems-reports-27-revenue-growth/ 2025-11-13T10:23:36+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/KORU-Medical-Systems-Reports-27-Revenue-Growth-in-Q3-and-Increases-Full-Year-2025-Outlook_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Medical_11zon-1024x681.webp https://thepharmadata.com/hiv-gileads-bictegravir-lenacapavir-hiv-phase-3/ 2025-11-14T10:00:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Gileads-Bictegravir–Lenacapavir-HIV-Pill-Meets-Phase-3-ARTISTRY-1-Goal.webp https://thepharmadata.com/wp-content/uploads/2025/11/pexels-padrinan-3936366-1024x681.jpg https://thepharmadata.com/cancer-patients-survey-finds-non-muscle-bladder/ 2025-11-14T10:14:43+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Survey-Finds-Non–Muscle-Invasive-Bladder-Cancer-Patients-Want-More-Dialogue-in-Their-Care.webp https://thepharmadata.com/wp-content/uploads/2025/11/Cancer-2_11zon-1024x681.webp https://thepharmadata.com/flightpath-biosciences-boosts-pipeline-with-new/ 2025-11-14T10:26:50+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Flightpath-Biosciences-Boosts-Pipeline-with-New-Drug-License-Launches-New-Brand-Identity_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Flightpath-Biosciences_11zon-1024x681.webp https://thepharmadata.com/inflammasome-therapeutics-healey-amg-center/ 2025-11-14T10:36:46+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Inflammasome-Therapeutics-Healey-AMG-Center-Launch-ALS-Treatment-Collaboration_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Inflammasome-Therapeutics_11zon-1024x682.webp https://thepharmadata.com/jsr-life-sciences-reaches-definitive-agreement/ 2025-11-14T10:44:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/JSR-Life-Sciences-Reaches-Definitive-Agreement-to-Transfer-Crown-Bioscience-to-Adicon_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Life-Sciences-2_11zon-1024x681.webp https://thepharmadata.com/jj-moves-to-redefine-cancer-treatment-through/ 2025-11-18T09:59:11+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/JJ-Moves-to-Redefine-Cancer-Treatment-Through-Halda-Therapeutics-Buyout_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Cancer-3_11zon-1024x681.webp https://thepharmadata.com/scribe-therapeutics-showcases-key-ascvd-2025/ 2025-11-18T10:12:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Scribe-Therapeutics-Showcases-Key-ASCVD-Lipid-Driver-Data-at-AHA-2025_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Therapeutics-4_11zon-1024x681.webp https://thepharmadata.com/solve-therapeutics-secures-120m-to-advance/ 2025-11-18T10:25:28+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Solve-Therapeutics-Secures-120M-to-Advance-Next-Generation-ADC-Therapies-for-Solid-Tumors_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Solve-Therapeutics-2_11zon-1024x681.webp https://thepharmadata.com/sonoma-biotherapeutics-names-stephen-dilly-ceo/ 2025-11-18T10:44:30+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Sonoma-Biotherapeutics-Names-Stephen-Dilly-CEO-as-Jeff-Bluestone-Becomes-Advisor_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Sonoma-Biotherapeutics_11zon-1024x530.webp https://thepharmadata.com/corrixr-therapeutics-shares-preclinical-data/ 2025-11-18T11:08:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/CorriXR-Therapeutics-Shares-Preclinical-Data-on-CRISPR-Approach-to-Defeat-Solid-Tumor-Drug-Resistance-2_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/CorriXR-1024x576.webp https://thepharmadata.com/enanta-pharmaceuticals-announces-fiscal-q4-2025/ 2025-11-18T11:20:28+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Enanta-Pharmaceuticals-Announces-Fiscal-Q4-and-Full-Year-2025-Financial-Results_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Pharmaceuticals-2_11zon-1-1024x681.webp https://thepharmadata.com/agenus-names-dr-jose-iglesias-as-chief-medical/ 2025-11-19T09:47:05+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Agenus-Names-Dr.-Jose-Iglesias-as-Chief-Medical-Affairs-Officer.webp https://thepharmadata.com/wp-content/uploads/2025/10/Agenus_11zon-1.webp https://thepharmadata.com/nuvig-therapeutics-appoints-dr-celia-j-f-lin/ 2025-11-19T09:54:31+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Nuvig-Therapeutics-Appoints-Dr.-Celia-J.F.-Lin-to-Lead-as-Chief-Medical-Officer_11zon-1.webp https://thepharmadata.com/wp-content/uploads/2025/09/Nuvig-Therapeutics-Names-David_11zon.webp https://thepharmadata.com/fda-approves-poherdy-first-us-biosimilar/ 2025-11-19T10:03:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/FDA-Approves-POHERDY®-First-US-Biosimilar-to-PERJETA.webp https://thepharmadata.com/wp-content/uploads/2025/11/POHERDY_11zon-1024x1024.webp https://thepharmadata.com/christianacare-unveils-new-organoid-core/ 2025-11-19T10:09:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/ChristianaCare-Unveils-New-Organoid-Core-to-Advance-Personalized-Cancer-Therapies_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/ChristianaCare-1024x419.webp https://thepharmadata.com/lifordi-immunotherapeutics-gains-investment/ 2025-11-19T10:18:04+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Lifordi-Immunotherapeutics-Gains-Investment-from-Sanofi-Ventures_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Lifordi-Immunotherapeutics_11zon.webp https://thepharmadata.com/arrowhead-pharmaceuticals-gains-fda-nod/ 2025-11-19T10:26:04+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Arrowhead-Pharmaceuticals-Gains-FDA-Nod-for-REDEMPLO®-a-New-Therapy-Targeting-Triglyceride-Reduction-in-FCS.webp https://thepharmadata.com/wp-content/uploads/2025/03/Arrowhead-Highlights-Clinical-Stage-RNAi-Therapies-for-Obesity-and-Metabolic-Diseases_11zon.webp https://thepharmadata.com/parse-biosciences-unveils-ffpe-compatible/ 2025-11-19T10:32:16+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Parse-Biosciences-Unveils-FFPE-Compatible-Single-Cell-Barcoding-Tech_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/QIAGEN-Buys-Parse-Biosciences-to-Expand-Single-Cell-Tools_11zon-1024x681.webp https://thepharmadata.com/boston-cell-standards-unveils-calibration-her2/ 2025-11-20T09:56:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Boston-Cell-Standards-Unveils-Calibration-Breakthrough-to-Enhance-Accuracy-in-HER2-Low-Breast-Cancer-Testing_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/pexels-fayette-reynolds-m-s-181007507-11198503_11zon-1024x681.webp https://thepharmadata.com/kalivir-roche-partner-to-test-vet3-tgi/ 2025-11-20T10:08:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/KaliVir-Roche-Partner-to-Test-VET3-TGI-Tecentriq®-in-Advanced-Tumors.webp https://thepharmadata.com/wp-content/uploads/2025/08/Roche_11zon-1024x597.webp https://thepharmadata.com/avenzo-therapeutics-names-scott-lipman-as-new/ 2025-11-20T10:18:19+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Avenzo-Therapeutics-Names-Scott-Lipman-as-New-Chief-Financial-Officer_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Therapeutics-3_11zon-1024x682.webp https://thepharmadata.com/tinostamustine-demonstrates-clinical-phase-1/ 2025-11-20T10:26:08+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Tinostamustine-Demonstrates-Early-Clinical-Activity-in-Phase-1-Glioblastoma-Study_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Tinostamustine-Shows-Early-Signals-of-Activity-in-Phase-1-Glioblastoma-Trial_11zon-1024x768.webp https://thepharmadata.com/oncolytics-biotech-reaches-fda-agreement/ 2025-11-20T10:46:16+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Oncolytics-Biotech®-Reaches-FDA-Agreement-on-Pivotal-Trial-Design-for-Pelareorep-in-First-Line-Pancreatic-Cancer.webp https://thepharmadata.com/wp-content/uploads/2025/11/Oncolytics_11zon-1024x681.webp https://thepharmadata.com/ziihera-tevimbra-shows-strong-phase-3/ 2025-11-20T11:01:10+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/ZIIHERA®-TEVIMBRA®-Shows-Strong-Phase-3-Results-in-First-Line-HER2-Gastroesophageal-Cancer.webp https://thepharmadata.com/wp-content/uploads/2024/11/Jazz-Pharma-Gains-FDA-Approval-for-Ziihera®-to-Treat-Advanced-HER2-Biliary-Tract-Cancer.webp https://thepharmadata.com/hercules-pharmaceuticals-joins-healthcare/ 2025-11-20T11:06:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Hercules-Pharmaceuticals-Joins-Healthcare-Distribution-Alliance-Timothy-Ward-Appointed-to-Board_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Hercules-Pharmaceuticals_11zon-1024x682.webp https://thepharmadata.com/contineum-therapeutics-releases-phase-2-rrms-307/ 2025-11-22T10:32:40+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/physical-therapy-2133286_1280_11zon-2.webp https://thepharmadata.com/wp-content/uploads/2025/04/Contineum-Therapeutics-Names-Timothy-Watkins-as-CMO-and-Head-of-Development.webp https://thepharmadata.com/quanterix-announces-strategic-board/ 2025-11-22T10:39:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Quanterix-Announces-Strategic-Board-and-Leadership-Transitions-to-Accelerate-Future-Growth_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/08/Quanterix-Accelerator-Lab-Secures-Prestigious-New-York-State-Clinical-Laboratory-Permit_11zon.webp https://thepharmadata.com/beone-medicines-highlights-advances-in-ash-2025/ 2025-11-22T10:50:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/BeOne-Medicines-Highlights-Advances-in-B-Cell-Malignancy-Treatments-at-ASH-2025_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/08/BeOne_11zon.webp https://thepharmadata.com/agc-biologics-to-produce-aavantgardes-dual/ 2025-11-22T11:01:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/AGC-Biologics-to-Produce-AAVantgardes-Dual-Vector-Gene-Therapies.webp https://thepharmadata.com/wp-content/uploads/2025/07/AGC-Biologics.webp https://thepharmadata.com/blue-lake-biotech-to-resume-enrollment-blb201/ 2025-11-22T11:08:32+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Blue-Lake-Biotech-to-Resume-Enrollment-in-BLB201-Toddler-Trial_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Blue-Lake-Biotech_11zon.webp https://thepharmadata.com/parabilis-medicines-reports-encouraging-001-2025/ 2025-11-22T11:20:11+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Parabilis-Medicines-Reports-Encouraging-Early-FOG-001-Data-in-ACP-at-SNO-2025_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Parabilis-Medicines_11zon-1024x682.webp https://thepharmadata.com/u-s-fda-grants-approval-to-padcev-and-keytruda/ 2025-11-22T11:30:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/U.S.-FDA-Grants-Approval-to-PADCEV®-and-Keytruda®-Combination-for-Select-Bladder-Cancer-Patients.webp https://thepharmadata.com/wp-content/uploads/2025/11/PADCEV_11zon.webp https://thepharmadata.com/astrazeneca-to-invest-2b-in-maryland-2600-jobs/ 2025-11-22T11:37:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/AstraZeneca-to-Invest-2B-in-Maryland-Manufacturing-Create-2600-Jobs_11zon.webp https://thepharmadata.com/wp-content/uploads/2024/11/AstraZeneca.webp https://thepharmadata.com/microsize-and-schedio-group-announce/ 2025-11-25T10:01:04+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Microsize-and-Schedio-Group-Announce-Acquisition-of-Lonzas-Micro-Macinazione-Facility-in-Switzerland.webp https://thepharmadata.com/wp-content/uploads/2025/11/Microsize-and-Schedio-Group-Announce-Acquisition-of-Lonzas-Micro-Macinazione-Facility-in-Switzerland-1.webp https://thepharmadata.com/kelonia-unveils-first-in-human-in-vivo-ash-2025/ 2025-11-25T10:33:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Kelonia-Unveils-First-in-Human-In-Vivo-BCMA-CAR-T-Data-at-ASH-2025_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Kelonia-Therapeutics_11zon.webp https://thepharmadata.com/shore-study-confirms-heartcare-prognostic-power/ 2025-11-25T10:45:27+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/SHORE-Study-Confirms-HeartCares-Prognostic-Power-in-Transplant-Patients.webp https://thepharmadata.com/wp-content/uploads/2025/11/HeartCare-1024x576.webp https://thepharmadata.com/seragene-revised-announcement-to-cures-invests/ 2025-11-25T10:52:24+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Corrected-Release-Pathway-to-Cures-Announces-Investment-in-SeraGene-Therapeutics_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/SeraGene-Therapeutics_11zon.webp https://thepharmadata.com/vyome-appoints-dr-aditya-bardia-as-senior/ 2025-11-26T12:14:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Vyome-Appoints-Dr.-Aditya-Bardia-as-Senior-Medical-Advisor_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Vyome_11zon.webp https://thepharmadata.com/enigma-biomedical-usa-receives-mjff-grant/ 2025-11-26T12:30:27+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Enigma-Biomedical-USA-Receives-MJFF-Grant-for-Novel-α-Synuclein-PET-Biomarker.webp https://thepharmadata.com/wp-content/uploads/2025/11/Enigma_11zon-1024x410.webp https://thepharmadata.com/zetagen-therapeutics-raises-series-b1/ 2025-11-26T12:42:08+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/foot-reflexology-3781151_1280_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Zetagen-Therapeutics_11zon.webp https://thepharmadata.com/realta-life-sciences-announces-appointment/ 2025-11-26T12:50:23+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/ReAlta-Life-Sciences-Announces-Appointment-of-Dr.-Howard-Berman-as-Executive-Chairman_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/ReAlta_11zon.webp https://thepharmadata.com/longhorn-validates-primestore-mtm-for-global-tb/ 2025-11-26T13:00:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Longhorn-Validates-PrimeStore®-MTM-for-Global-TB-Screening.webp https://thepharmadata.com/wp-content/uploads/2025/11/Longhorn.webp https://thepharmadata.com/allurion-reports-early-results-combining-program/ 2025-11-26T13:07:27+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Allurion-Reports-Early-Results-Combining-Program-With-Low-Dose-Tirzepatide_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Allurion_11zon.webp https://thepharmadata.com/edgeone-medical-names-marty-shelton-chief/ 2025-11-27T10:16:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/EdgeOne-Medical-Names-Marty-Shelton-Chief-Operating-Officer_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/EdgeOne_11zon-1024x691.webp https://thepharmadata.com/real-world-evidence-confirms-repathas-sustained/ 2025-11-27T10:27:02+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Real-World-Evidence-Confirms-Repathas-Sustained-Cardiovascular-Benefits.webp https://thepharmadata.com/wp-content/uploads/2025/11/Target_11zon-1024x536.webp https://thepharmadata.com/arrowhead-pharmaceuticals-announces-year-2025/ 2025-11-27T10:33:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Arrowhead-Pharmaceuticals-Announces-Full-Year-2025-Financial-Results_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/03/Arrowhead-Highlights-Clinical-Stage-RNAi-Therapies-for-Obesity-and-Metabolic-Diseases_11zon.webp https://thepharmadata.com/voyxact-fda-grants-accelerated-approval-otsukas/ 2025-11-27T10:42:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/FDA-Grants-Accelerated-Approval-to-Otsukas-VOYXACT-for-IgAN-Proteinuria-Reduction.webp https://thepharmadata.com/wp-content/uploads/2025/11/VOYXACT_11zon.webp https://thepharmadata.com/corstasis-and-cardiovascular-logistics-partner/ 2025-11-27T11:16:41+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/HeartCare.webp https://thepharmadata.com/wp-content/uploads/2025/11/Corstasis.webp https://thepharmadata.com/health-african-leaders-urge-systems-icasa-2025/ 2025-11-28T10:20:33+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/African-Leaders-Urge-Stronger-Health-Systems-at-ICASA-2025_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Health_11zon-1024x682.webp https://thepharmadata.com/celltrion-wins-health-approval-eydenzelt/ 2025-11-28T10:26:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/Celltrion-Wins-Health-Canada-Approval-for-Eydenzelt-Biosimilar_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Celltrion_11zon.webp https://thepharmadata.com/cancer-teambest-global-issues-open-letter/ 2025-11-29T10:18:10+05:30 https://thepharmadata.com/wp-content/uploads/2025/11/TeamBest-Global-Issues-Open-Letter-to-AROI-on-Affordable-Cancer-and-Vascular-Care_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/11/Cancer_11zon-1-1024x682.webp https://thepharmadata.com/agilent-unveils-21-cfr-part-11-compliant/ 2025-12-02T10:20:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Agilent-Unveils-21-CFR-Part-11–Compliant-Software-for-xCELLigence-RTCA-eSight-1.webp https://thepharmadata.com/wp-content/uploads/2024/12/Agilents-PD-L1-IHC-28-8-pharmDx-Companion-Diagnostic-Assay-Earns-European-IVDR-Certification_11zon-1024x682.webp https://thepharmadata.com/circle-pharma-announces-appointment-of-dr-anne/ 2025-12-02T10:32:25+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Circle-Pharma-Appoints-Anne-E.-Borgman-M.D.-as-Chief-Medical-Officer-Strengthening-Leadership-Team-to-Advance-Next-Generation-Macrocycle-Oncology-Pipeline.webp https://thepharmadata.com/wp-content/uploads/2025/12/Circle-Pharma_11zon-1024x633.webp https://thepharmadata.com/incyte-names-richard-hoffman-executive-vice/ 2025-12-02T10:46:49+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Incyte-Names-Richard-Hoffman-Executive-Vice-President-and-General-Counsel.webp https://thepharmadata.com/mirum-pharmaceuticals-begins-bloom-phase-2-trial-with-first-patient-dosed-evaluating-mrm-3379-for-fragile-x-syndrome/ 2025-12-02T10:52:34+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Mirum-Pharmaceuticals-Begins-BLOOM-Phase-2-Trial-with-First-Patient-Dosed-Evaluating-MRM-3379-for-Fragile-X-Syndrome.webp https://thepharmadata.com/omeros-corporation-finalizes-asset-purchase-3/ 2025-12-02T11:01:45+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Omeros-Corporation-Finalizes-Asset-Purchase-and-License-Agreement-with-Novo-Nordisk-for-MASP-3-Inhibitor-Zaltenibart.webp https://thepharmadata.com/octave-bioscience-partners-with-quest-diagnostics-to-expand-msda-test-access/ 2025-12-02T12:01:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Octave-Bioscience-Partners-with-Quest-Diagnostics-to-Expand-MSDA-Test-Access.webp https://thepharmadata.com/vistagen-announces-appointment-of-nick-tressler/ 2025-12-02T12:21:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Vistagen-Announces-Appointment-of-Nick-Tressler-as-Chief-Financial-Officer.webp https://thepharmadata.com/cellares-names-ali-soleymannezhad-as-cco/ 2025-12-02T12:34:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Cellares-Names-Ali-Soleymannezhad-as-CCO-to-Drive-Global-Expansion-and-IPO-Prep.webp https://thepharmadata.com/altpep-shows-sobin-ad-peptide-improves-2025/ 2025-12-02T12:40:26+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/AltPep-Shows-SOBIN-AD-Peptide-Improves-Alzheimers-Behavior-in-Preclinical-Study-at-CTAD-2025.webp https://thepharmadata.com/janux-reports-promising-phase-1-results-janx007/ 2025-12-02T12:53:40+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Janux-Reports-Promising-Phase-1-Results-for-JANX007-in-mCRPC.webp https://thepharmadata.com/samsung-bioepis-introduces-denosumab-biosimilars/ 2025-12-02T13:04:06+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Samsung-Bioepis-Introduces-Denosumab-Biosimilars-OBODENCE™-and-XBRYK™-to-European-Market.webp https://thepharmadata.com/advancell-launches-phase-2-expansion-advc001/ 2025-12-03T10:14:40+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/AdvanCell-Launches-Phase-2-Expansion-Trial-of-ADVC001-a-Novel-Targeted-Alpha-Therapy-for-Prostate-Cancer.webp https://thepharmadata.com/latus-bio-receives-ind-clearance-101-in-cln2/ 2025-12-03T10:25:01+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Latus-Bio-Receives-IND-Clearance-and-Key-FDA-Designations-for-LTS-101-in-CLN2-Disease.webp https://thepharmadata.com/strand-therapeutics-welcomes-jeb-keiper-to-its/ 2025-12-03T10:42:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Strand-Therapeutics-Strengthens-Strategic-Leadership-with-Appointment-of-Industry-Veteran-Jeb-Keiper-to-Board-of-Directors.webp https://thepharmadata.com/sarah-cannon-to-present-blood-cancer-2025/ 2025-12-03T11:32:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Sarah-Cannon-to-Present-Blood-Cancer-Disorder-Advances-at-2025-ASH-Meeting.webp https://thepharmadata.com/johnson-johnsons-imaavy-approved/ 2025-12-03T11:01:39+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Johnson-Johnsons-IMAAVY®-nipocalimab-Approved-by-European-Commission-for-Broad-gMG-Population-Offering-Sustained-Disease-Control.webp https://thepharmadata.com/roche-gets-fda-clearance-and-ce-mark-for-first/ 2025-12-03T11:46:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/08/Roche_11zon.webp https://thepharmadata.com/fda-grants-priority-review-to-baxdrostat-new/ 2025-12-03T11:56:26+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/FDA-Grants-Priority-Review-to-Baxdrostat-New-Drug-Application-for-Hard-to-Control-Hypertension-in-the-U.S.webp https://thepharmadata.com/aetna-medicaid-boosts-support-to-combat-hunger/ 2025-12-03T12:04:19+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Untitled-design-3.webp https://thepharmadata.com/zoetis-showcases-rd-leadership-and-growth/ 2025-12-03T12:28:08+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Zoetis-Showcases-RD-Leadership-and-Long-Term-Growth-Potential-in-Innovation-Webcast.png https://thepharmadata.com/bayer-launches-phase-iii-trial-of-long-acting/ 2025-12-03T12:19:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Bayer-Launches-Phase-III-Trial-of-Long-Acting-IUS-for-Nonatypical-Endometrial-Hyperplasia.webp https://thepharmadata.com/icon-survey-rising-trial-startup-delays/ 2025-12-03T12:33:14+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/ICON-Survey-Rising-Trial-Startup-Delays-Highlight-Need-for-Human-Centred-Site-Activation.webp https://thepharmadata.com/clinical-trials-lilly-and-iu-partner-to-broaden/ 2025-12-04T11:10:25+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Lilly-and-IU-Partner-to-Broaden-Hoosiers-Access-to-Clinical-Trials-and-Cutting-Edge-Treatments.webp https://thepharmadata.com/johnson-johnson-partners-with-naomi-watts/ 2026-11-10T11:28:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Johnson-Johnson-Partners-with-Naomi-Watts-to-Spotlight-Eye-Exams-as-Essential-Self-Care-for-Women-Over-40.webp https://thepharmadata.com/bristol-myers-squibb-advances-adept-2-phase-3/ 2025-12-04T11:36:33+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Bristol-Myers-Squibb-Advances-ADEPT-2-Phase-3-Trial-for-Alzheimers-Related-Psychosis.webp https://thepharmadata.com/pediatric-study-data-on-bayers-2025/ 2025-12-04T11:26:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Pediatric-Study-Data-on-Bayers-Investigational-MRI-Contrast-Agent-Showcased-at-RSNA-2025.webp https://thepharmadata.com/biontech-meets-minimum-requirement-for-curevac/ 2025-12-04T11:45:43+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/BioNTech-Meets-Minimum-Requirement-for-CureVac-Exchange-Offer.webp https://thepharmadata.com/alnylam-pharmaceuticals-announces-board/ 2025-12-04T11:53:17+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Alnylam-Pharmaceuticals-Announces-Board-of-Directors-Updates.webp https://thepharmadata.com/cipla-collaborates-with-stempeutics-to-launch/ 2025-12-04T12:06:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Cipla-Collaborates-with-Stempeutics-to-Launch-Stem-Cell-Therapy-for-Knee-Osteoarthritis.webp https://thepharmadata.com/fda-conditionally-approves-exzolt-cattle-ca1/ 2025-12-05T15:44:06+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Merck-Animal-Health-Secures-FDA-Conditional-Approval-for-EXZOLT™-CATTLE-CA1—A-Groundbreaking-Tool-Against-New-World-Screwworm-and-Cattle-Fever-Tick.webp https://thepharmadata.com/breyanzi-approved-as-first-car-t-therapy/ 2025-12-05T15:49:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Bristol-Myers-Squibbs-Breyanzi-Becomes-First-and-Only-CAR-T-Cell-Therapy-Approved-by-FDA-for-Relapsed-or-Refractory-Marginal-Zone-Lymphoma.webp https://thepharmadata.com/aetna-enhances-efforts-to-streamline-experiences/ 2025-12-05T16:09:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Aetna-Accelerates-National-Strategy-to-Simplify-Healthcare-for-Providers-and-Patients-Through-Innovation-AI-and-Integrated-Care-Models.webp https://thepharmadata.com/mediabayer-launches-phase-iia-clinical-trial/ 2025-12-05T16:13:47+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Bayer-Launches-Phase-IIa-Clinical-Trial-of-Novel-Therapy-for-Alport-Syndrome.webp https://thepharmadata.com/egypt-attains-self-sufficiency-in-plasma-derived/ 2025-12-05T16:22:09+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Egypt-Attains-Self-Sufficiency-in-Plasma-Derived-Medicines-with-Support-from-Grifols.webp https://thepharmadata.com/biocytogen-ide034-a-bispecific-antibody-drug/ 2025-12-06T10:18:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/IDE034-a-Bispecific-Antibody-Drug-Conjugate-Licensed-by-Biocytogen-to-IDEAYA-Receives-FDA-IND-Clearance_11zon.webp https://thepharmadata.com/organ-ossium-health-to-unveil-clinical-data-2025/ 2025-12-06T10:45:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/pexels-tima-miroshnichenko-9574533_11zon.webp https://thepharmadata.com/zoetis-secures-health-canada-approval/ 2025-12-06T10:57:46+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Zoetis-Secures-Health-Canada-Approval-for-Portela™-relfovetmab-Injection-to-Relieve-Osteoarthritis-Pain-in-Cats.webp https://thepharmadata.com/biogen-and-stoke-promising-zorevunersen-2025/ 2025-12-06T11:21:57+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Biogen_11zon.webp https://thepharmadata.com/who-most-countries-advance-on-universal-health/ 2025-12-06T11:44:01+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Most-Countries-Advance-on-Universal-Health-Coverage-but-Challenges-Persist-–-WHOWorld-Bank-1.webp https://thepharmadata.com/johnson-johnsons-inlexzo-achieves-74/ 2025-12-06T11:59:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/10/Johnson-Johnson-Urges-Shareholders-to-Reject-Tutanota-Mini-Tender-Offer_11zon.webp https://thepharmadata.com/blueprint-medicines-highlights-long-term2025/ 2025-12-06T12:11:14+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Blueprint-Medicines-Highlights-Long-Term-AYVAKIT®-Benefits-in-Systemic-Mastocytosis-at-ASH-2025.webp https://thepharmadata.com/roche-shows-lunsumios-potential-in-earlier/ 2025-12-09T10:10:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Roche-Highlights-Lunsumio-Data-Demonstrating-Promise-in-Earlier-Treatment-Settings-for-Both-Indolent-and-Aggressive-Lymphomas.webp https://thepharmadata.com/bristol-myers-squibb-showcases-new-data-2025/ 2025-12-09T10:14:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Bristol-Myers-Squibb-Showcases-New-Data-in-Targeted-Protein-Degradation-and-Cell-Therapy-for-Lymphoma-at-ASH-2025.webp https://thepharmadata.com/genmab-reports-promising-epcoritamab-data/ 2025-12-09T10:31:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Genmab-Reports-Promising-Epcoritamab-Data-in-Richter-Transformation-from-EPCORE®-CLL-1-Trial.webp https://thepharmadata.com/brukinsa-achieves-landmark-74-six-progression/ 2025-12-09T10:25:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/BRUKINSA-Achieves-Landmark-74-Six-Year-Progression-Free-Survival-in-Treatment-Naive-Chronic-Lymphocytic-Leukemia-Patients.webp https://thepharmadata.com/global-experts-convene-in-discuss-radiation/ 2025-12-09T17:12:08+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Global-experts-convene-in-Vienna-to-discuss-radiation-protection-in-medicine.webp https://thepharmadata.com/jim-lang-joins-halozymes-board-of-directors/ 2025-12-09T17:22:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Jim-Lang-Joins-Halozymes-Board-Bringing-30-Years-of-Leadership-Experience.png https://thepharmadata.com/lilly-to-invest-6-billion-in-new-alabama/ 2025-12-10T10:55:26+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Lilly-to-Invest-6-Billion-in-New-Alabama-Facility-for-Active-Pharmaceutical-Ingredient-Manufacturing.png https://thepharmadata.com/majestec-3-phase-3-data-show-tecvayli/ 2025-12-10T12:23:32+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/MajesTEC-3-TECVAYLI-DARZALEX-FASPRO-Shows-Potential-as-New-Second-Line-Standard-in-RR-Multiple-Myeloma.webp https://thepharmadata.com/roche-introduces-new-ce-marked-pcr-test/ 2025-12-10T12:29:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Roche-Introduces-New-CE-Marked-PCR-Test-to-Enhance-Diagnostic-Accuracy-for-Vaginitis-in-Women.webp https://thepharmadata.com/novartis-ianalumab-extends-disease-control/ 2025-12-10T12:35:27+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Novartis-Ianalumab-Extends-Disease-Control-in-Immune-Thrombocytopenia-with-Just-Four-Monthly-Doses.webp https://thepharmadata.com/biontech-and-bristol-myers-squibb-reveal/ 2025-12-10T12:47:45+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/BioNTech-BMS-Report-Promising-Phase-2-Results-for-Pumitamig-in-Advanced-Triple-Negative-Breast-Cancer-2.webp https://thepharmadata.com/cvs-health-revises-guidance-showcases-business/ 2025-12-10T12:51:02+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/CVS-Health-Revises-Guidance-Showcases-Business-Strength-and-Unveils-Healthcare-Reimagining-Strategy-at-Investor-Day.webp https://thepharmadata.com/askbios-ab-1005-and-ab-1002-granted-japans/ 2025-12-10T12:55:09+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/AskBios-AB-1005-and-AB-1002-Granted-Japans-Pioneering-Regenerative-Medicine-Product-Designation-2.webp https://thepharmadata.com/icon-2025-global-biotech-survey-confirms-chinas/ 2025-12-10T13:03:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/ICON-2025-Survey-Shows-China-Leading-Biotech-Highlights-Opportunities-for-Western-Firms.webp https://thepharmadata.com/teva-submits-nda-for-once-monthly-olanzapine/ 2025-12-10T13:05:43+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Teva-Submits-NDA-for-Once-Monthly-Olanzapine-Injection-for-Schizophrenia.webp https://thepharmadata.com/roches-giredestrant-cuts-risk-of-invasive/ 2025-12-12T11:04:23+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Roches-Giredestrant-Cuts-Risk-of-Invasive-Disease-Recurrence-or-Death-by-30-in-ER-Positive-Early-Stage-Breast-Cancer.webp https://thepharmadata.com/tukysa-boosts-pfs-by-8-months-in-line-her2/ 2025-12-12T11:12:10+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/TUKYSA-Added-to-First-Line-Maintenance-Therapy-Boosts-Median-Progression-Free-Survival-by-More-Than-8-Months-in-HER2-Metastatic-Breast-Cancer-Patients.webp https://thepharmadata.com/roche-expands-mass-spec-menu-with-ce-marked/ 2025-12-12T11:26:24+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Roche-Expands-Mass-Spec-Menu-with-CE-Marked-Antibiotic-Monitoring—Broadest-IVD-Offering.webp https://thepharmadata.com/fda-approves-uplizna-for-the-treatment-adults/ 2025-12-12T11:20:41+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/FDA-Approves-Uplizna®-for-the-Treatment-of-Generalized-Myasthenia-Gravis-in-Adults.webp https://thepharmadata.com/bristol-myers-squibb-fda-grants-priority-review/ 2025-12-12T11:31:50+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/FDA-Grants-Priority-Review-to-Bristol-Myers-Squibbs-Opdivo®-Plus-Chemo-for-Hodgkin-Lymphoma.webp https://thepharmadata.com/fda-approves-blujepa-as-first-oral-treatment/ 2025-12-12T11:38:46+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/FDA-Approves-Blujepa-Gepotidacin-as-First-Oral-Treatment-for-Uncomplicated-Urogenital-Gonorrhea-2.webp https://thepharmadata.com/alnylam-announces-partial-buyback-of-1-00-27/ 2025-12-12T11:43:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Alnylam-Announces-Partial-Buyback-of-1.00-Convertible-Senior-Notes-Due-2027.webp https://thepharmadata.com/bio-techne-and-wyss-center-geneva-3d-biology/ 2025-12-12T11:58:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Bio-Techne-and-Wyss-Center-Geneva-Collaborate-to-Advance-Automated-3D-Multiomics-and-Accelerate-Spatial-Biology.png https://thepharmadata.com/sarepta-therapeutics-completes-refinancing-291/ 2025-12-12T12:06:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Sarepta-Therapeutics-Completes-Refinancing-of-291-Million-in-1.25-Convertible-Senior-Notes-Due-2027-2.webp https://thepharmadata.com/updated-data-reinforce-inluriyo-monotherapy/ 2025-12-13T10:21:11+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/Updated-Data-Reinforce-Inluriyo™-imlunestrant-Efficacy—Monotherapy-and-with-Verzenio®—in-ERHER2−-Advanced-Breast-Cancer.webp https://thepharmadata.com/ema-recommends-higher-wegovy-dose-weight-loss/ 2025-12-13T10:46:40+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/EMA-Recommends-Higher-Wegovy®-Dose-for-20.7-Average-Weight-Loss-in-Obesity.webp https://thepharmadata.com/fda-approves-akeega-first-precision-therapy-54/ 2025-12-13T10:45:01+05:30 https://thepharmadata.com/wp-content/uploads/2025/12/FDA-Approves-AKEEGA®—First-Precision-Therapy-for-BRCA2-mCSPC-Cutting-Progression-Risk-by-54.webp